News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
651,660 Results
Type
Article (49845)
Company Profile (229)
Press Release (601568)
Multimedia
Podcasts (179)
Webinars (26)
Section
Business (178227)
Career Advice (2619)
Deals (32846)
Drug Delivery (149)
Drug Development (79665)
Employer Resources (171)
FDA (16686)
Job Trends (13779)
News (316114)
Policy (32809)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2450)
Academic (1)
Accelerated approval (39)
Adcomms (36)
Allergies (147)
Alliances (45130)
ALS (180)
Alzheimer's disease (1765)
Antibody-drug conjugate (ADC) (357)
Approvals (16869)
Artificial intelligence (571)
Autoimmune disease (179)
Automation (36)
Bankruptcy (330)
Best Places to Work (10202)
BIOSECURE Act (23)
Biosimilars (210)
Biotechnology (113)
Bladder cancer (165)
Brain cancer (59)
Breast cancer (638)
Cancer (4932)
Cardiovascular disease (432)
Career advice (2210)
Career pathing (42)
CAR-T (278)
CDC (66)
Celiac Disease (1)
Cell therapy (777)
Cervical cancer (36)
Clinical research (68289)
Collaboration (1727)
Company closure (5)
Compensation (1204)
Complete response letters (78)
COVID-19 (2799)
CRISPR (94)
C-suite (880)
Cystic fibrosis (144)
Data (6288)
Decentralized trials (2)
Denatured (51)
Depression (155)
Diabetes (508)
Diagnostics (5992)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (269)
Drug pricing (227)
Drug shortages (35)
Duchenne muscular dystrophy (251)
Earnings (74427)
Editorial (69)
Employer branding (20)
Employer resources (152)
Events (100617)
Executive appointments (978)
FDA (19910)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (21)
Funding (1415)
Gene editing (205)
Generative AI (50)
Gene therapy (645)
GLP-1 (1129)
Government (4380)
Grass and pollen (8)
Guidances (381)
Healthcare (16128)
HIV (72)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (297)
Immuno-oncology (70)
Indications (125)
Infectious disease (3090)
Inflammatory bowel disease (206)
Inflation Reduction Act (15)
Influenza (120)
Intellectual property (255)
Interviews (480)
IPO (15521)
IRA (59)
Job creations (3881)
Job search strategy (1822)
JPM (73)
Kidney cancer (19)
Labor market (88)
Layoffs (631)
Leadership (44)
Legal (7942)
Liver cancer (96)
Longevity (17)
Lung cancer (664)
Lymphoma (378)
Machine learning (42)
Management (59)
Manufacturing (836)
MASH (177)
Medical device (12005)
Medtech (12057)
Mergers & acquisitions (18394)
Metabolic disorders (1407)
mRNA (193)
Multiple sclerosis (173)
NASH (23)
Neurodegenerative disease (348)
Neuropsychiatric disorders (105)
Neuroscience (3103)
Neurotech (1)
NextGen: Class of 2026 (5545)
Non-profit (3471)
Now hiring (59)
Obesity (704)
Opinion (330)
Ovarian cancer (157)
Pain (211)
Pancreatic cancer (235)
Parkinson's disease (305)
Partnered (29)
Patents (519)
Patient recruitment (517)
Peanut (59)
People (54228)
Pharmaceutical (89)
Pharmacy benefit managers (34)
Phase 1 (21081)
Phase 2 (29655)
Phase 3 (23078)
Pipeline (5690)
Policy (351)
Postmarket research (2613)
Preclinical (8573)
Press Release (50)
Prostate cancer (261)
Psychedelics (59)
Radiopharmaceuticals (288)
Rare diseases (956)
Real estate (5465)
Recruiting (70)
Regulatory (25257)
Reports (45)
Research institute (2300)
Resumes & cover letters (431)
Rett syndrome (29)
RNA editing (18)
RSV (81)
Schizophrenia (162)
Series A (245)
Series B (188)
Service/supplier (14)
Sickle cell disease (107)
Special edition (29)
Spinal muscular atrophy (167)
Sponsored (47)
Startups (3387)
State (2)
Stomach cancer (21)
Supply chain (113)
Tariffs (101)
The Weekly (126)
Vaccines (1134)
Venture capital (97)
Weight loss (491)
Women's health (86)
Worklife (23)
Date
Today (273)
Last 7 days (870)
Last 30 days (2873)
Last 365 days (30005)
2026 (4804)
2025 (30204)
2024 (33906)
2023 (37973)
2022 (48623)
2021 (52398)
2020 (49774)
2019 (40610)
2018 (31004)
2017 (31308)
2016 (30111)
2015 (33776)
2014 (27447)
2013 (23079)
2012 (24736)
2011 (25346)
2010 (23294)
Location
Africa (804)
Alabama (74)
Alaska (7)
Arizona (259)
Arkansas (13)
Asia (40569)
Australia (6713)
California (11218)
Canada (2972)
China (1120)
Colorado (465)
Connecticut (502)
Delaware (342)
Europe (91971)
Florida (1706)
Georgia (339)
Hawaii (4)
Idaho (47)
Illinois (833)
India (71)
Indiana (477)
Iowa (22)
Japan (449)
Kansas (113)
Kentucky (39)
Louisiana (23)
Maine (76)
Maryland (1389)
Massachusetts (8179)
Michigan (283)
Minnesota (594)
Mississippi (5)
Missouri (119)
Montana (20)
Nebraska (26)
Nevada (119)
New Hampshire (67)
New Jersey (3041)
New Mexico (27)
New York (2933)
North Carolina (1486)
North Dakota (7)
Northern California (5556)
Ohio (312)
Oklahoma (17)
Oregon (38)
Pennsylvania (2188)
Puerto Rico (22)
Rhode Island (39)
South America (1178)
South Carolina (65)
South Dakota (1)
Southern California (4375)
Tennessee (163)
Texas (1674)
United States (39580)
Utah (290)
Virginia (276)
Washington D.C. (81)
Washington State (896)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
651,660 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zealand Pharma convenes its Annual General Meeting 2026
February 19, 2026
·
1 min read
Press Releases
Zealand Pharma Announces Financial Results for the Full Year 2025
February 19, 2026
·
13 min read
Press Releases
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Zealand Pharma announces positive Phase 1a topline results with Kv1.3 channel blocker ZP9830
February 18, 2026
·
7 min read
Press Releases
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
February 12, 2026
·
2 min read
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
Also on Thursday, Zealand held its Capital Markets Day in London,
outlining the strategy
for its weight management franchise in the near-term, including launching five products by 2030.
December 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma to participate in the 2025 Jefferies Global Healthcare Conference
November 13, 2025
·
1 min read
Obesity
Zealand Freezes Mid-Stage Obesity Asset To Focus on More Differentiated Drugs
The decision to pause dapiglutide will help Zealand focus investment into assets that have “the greatest potential for clinical differentiation” in obesity.
November 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma Announces Financial Results for the First Nine Months of 2025
November 13, 2025
·
10 min read
Obesity
Zealand’s GLP-1/GLP-2 Drug Elicits Over 11% Weight-Loss—With the Potential for More
Analysts at William Blair say dapiglutide’s 11.6% weight reduction at 28 weeks could still be better, given that Zealand’s study predominantly included men and enrolled patients with lower BMI at baseline.
June 20, 2025
·
2 min read
·
Tristan Manalac
1 of 65,166
Next
